Roundhill GLP-1 & Weight Loss ETF
OZEM
#2801
ETF Rang
€55.22 Mio.
Marktkapitalisierung
🇺🇸 US
Markt
28,62 €
Aktienkurs
0.65%
Veränderung (1 Tag)
30.07%
Veränderung (1 Jahr)

Roundhill GLP-1 & Weight Loss ETF - Bestände

ETF-Bestände zum Stand 17. August 2026Anzahl der Bestände: 27

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
12.24%
Eli Lilly & CoLLY6606
12.05%
Novo Nordisk A/SNVO168984
6.97%
Pfizer IncPFE165697
6.48%
CSPC Pharmaceutical Group Ltd1093 HK3728000
4.96%
Kailera Therapeutics IncKLRA176239
4.89%
Viking Therapeutics IncVKTX93822
4.33%
Amgen IncAMGN6634
4.32%
Zealand Pharma A/SZEAL DC55309
4.14%
Chugai Pharmaceutical Co Ltd4519 JP60500
4.10%
Ascletis Pharma Inc1672 HK1943000
3.76%
Hanmi Pharm Co Ltd128940 KS8509
3.41%
MBX Biosciences IncMBX31685
3.14%
Roche Holding AGROP SW4570
3.10%
AstraZeneca PLCAZN12621
3.04%
Structure Therapeutics IncGPCR35557
2.80%
Hansoh Pharmaceutical Group Co Ltd3692 HK420000
2.72%
Innovent Biologics Inc1801 HK145000
2.66%
United Laboratories International Holdings Ltd/The3933 HK1524000
2.30%
Jiangsu Hengrui Pharmaceuticals Co Ltd1276 HK218000
2.15%
Gubra A/SGUBRA DC23795
1.86%
Gilead Sciences IncGILD8569
1.67%
Rhythm Pharmaceuticals IncRYTM9188
1.24%
Shionogi & Co Ltd4507 JP44500
0.85%
First American Government Obligations Fund 12/01/2031FGXXX542281.09
0.79%
Wave Life Sciences IncWVE92938
0.44%
Cash & OtherCash&Other277575.57
-0.42%
SWISS FRANCCHF-215321.29